Duopharma Biotech Berhad Company Description

Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally.

The company offers consumer healthcare products comprising vitamins and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others.

It also provides specialty pharmaceutical drugs for targeted conditions, biosimilar products, and medical devices and consumables to patients with conditions, such as diabetes, cancer, cardiovascular diseases, renal diseases, and others.

The company’s product portfolio comprises vascor, acetan, covasc, crystorvas, bezartan, vytan, and vytocor; insugen and basalog one; kytron, zuhera, lebreta, trevive, and krabeva; and unihepa, ranofer, erysaa, bi-haemosol, and haemosol.

The company offers its products under the Champs, Flavettes, Eye Glo, Proviton, Naturalle, and Uphamol brands.

In addition, it offers property management and services; and distributes, imports, and exports chemical products.

The company was formerly known as CCM Duopharma Biotech Berhad and changed its name to Duopharma Biotech Berhad in February 2019.

Duopharma Biotech Berhad was founded in 1978 and is headquartered in Kuala Lumpur, Malaysia.

Duopharma Biotech Berhad

Country	Malaysia
Founded	1978
Industry	Pharmaceutical Preparations
Employees	1,650
CEO	Ariff bin Abdul Shatar

Contact Details

Address: CIMB HUB Kuala Lumpur, 50250 Malaysia
Phone	60 3 2162 0218
Website	duopharmabiotech.com

Stock Details

Ticker Symbol	DPHARMA
Exchange	Bursa Malaysia
Fiscal Year	January - December
Reporting Currency	MYR
SIC Code	2834

Key Executives

Name	Position
Ariff bin Abdul Shatar	Chief Executive Officer
Wu Chek	Chief Financial Officer